Showing results (1981-1990 of 2,560) with videos related to
Sort By:
Pageof 256
European Urology|October 11, 2014
Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical ProstatectomyJohn A Brockman, Shaheen Alanee, Andrew J Vickers, et al.Prostate Cancer and Prostatic Diseases|December 22, 2017
Post prostatectomy outcomes of patients with high-risk prostate cancer treated with neoadjuvant androgen blockadeRana R McKay, Bruce Montgomery, Wanling Xie, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2016
Epigenome-Wide Tumor DNA Methylation Profiling Identifies Novel Prognostic Biomarkers of Metastatic-Lethal Progression in Men Diagnosed with Clinically Localized Prostate CancerShanshan Zhao, Milan S Geybels, Amy Leonardson, et al.Molecular Cell|December 14, 2001
Unexpected effects of FERM domain mutations on catalytic activity of Jak3: structural implication for Janus kinasesY J Zhou, M Chen, N A Cusack, et al.Nature Communications|November 11, 2022
Stromal FOXF2 suppresses prostate cancer progression and metastasis by enhancing antitumor immunityDeyong Jia, Zhicheng Zhou, Oh-Joon Kwon, et al.Journal of Cutaneous Medicine and Surgery|April 24, 2019
Photodynamic Therapy for Genital Warts Causes Activation of Local ImmunityFang Xie, Haisheng S Yu, Rui Wang, et al.European Urology|February 14, 2018
Role of Surveillance Biopsy with No Cancer as a Prognostic Marker for Reclassification: Results from the Canary Prostate Active Surveillance StudyJames T Kearns, Anna V Faino, Lisa F Newcomb, et al.Nature Cancer|April 30, 2021
FYN-TRAF3IP2 induces NF-κB signaling-driven peripheral T cell lymphomaChristine S Moon, Clara Reglero, Jose R Cortes, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|May 20, 2011
Differential association of proinflammatory cytokines with left ventricular diastolic dysfunction in subjects with and without continuous ambulatory peritoneal dialysisJ-K Lee, H-H Lin, C-T Tsai, et al.European Urology|March 31, 2015
Precision Medicine in Active Surveillance for Prostate Cancer: Development of the Canary-Early Detection Research Network Active Surveillance Biopsy Risk CalculatorDonna P Ankerst, Jing Xia, Ian M Thompson, et al.Pageof 256